Applied DNA Sciences has received a follow-on order valued at more than $500,000 for a quantity of Linea DNA from a global manufacturer of in vitro diagnostics. The follow-on order was placed under a long-standing supply agreement for the bulk manufacture of Linea DNA used in the manufacture of a cancer diagnostic test. Applied DNA expects to deliver on the order over four quarterly shipments in calendar 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APDN:
- Applied DNA Sciences launches Mpox Clade I, Clade II testing service
- Applied DNA Sciences receives subcontract award from LRQA
- Applied DNA submits validation package to NYS Department of Health
- Applied DNA Sciences rating updated to Under Review at H.C. Wainwright
- 3 Penny Stocks to Watch Now, 8/20/24